POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IN PRIMARY CARE: DIAGNOSIS AND MANAGEMENT
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6253Keywords:
POTS, Postural Orthostatic Tachycardia Syndrome, Orthostatic Intolerance, Non-pharmacological Management, Primary CareAbstract
This article sets out a practical approach to recognising and managing postural orthostatic tachycardia syndrome (POTS) in primary care, drawing on current epidemiological, pathophysiological and therapeutic evidence. POTS is defined as a chronic syndrome of orthostatic intolerance with an excessive rise in heart rate on standing, without a meaningful fall in blood pressure, leading to a marked reduction in quality of life, particularly in young women. The article reviews the complex and heterogeneous causes of POTS, including a neuropathic component, hypovolaemia, a hyperadrenergic phenotype and a possible role for autoimmune mechanisms. It describes the typical clinical picture, the symptoms of orthostatic intolerance, and the wide range of coexisting conditions that together substantially limit patients’ functioning. A diagnostic scheme is proposed that fits the resources of a family doctor’s office, based on a focused history, physical examination, a simplified orthostatic test, basic laboratory work, an ECG, and clear criteria for specialist referral. On treatment, the article stresses the central role of non-pharmacological measures, including increased fluid and salt intake, compression garments, lifestyle changes and a gradual exercise programme, and discusses the supporting role of individually tailored drug treatment. The choice of treatment should reflect the mechanisms that dominate the clinical picture. The aim is to raise awareness of POTS among primary care physicians and to bring it into the differential diagnosis of patients reporting dizziness, palpitations, presyncope and chronic fatigue, so as to shorten the time to diagnosis and improve care for patients with chronic orthostatic intolerance.
References
Low, P. A., Sandroni, P., Joyner, M., & Shen, W. K. (2009). Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol, 20(3), 352–358. https://doi.org/10.1111/j.1540-8167.2008.01407.x
Sheldon, R. S., Grubb, B. P., 2nd, Olshansky, B., et al. (2015). 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm, 12(6), e41–e63. https://doi.org/10.1016/j.hrthm.2015.03.029
Shaw, B. H., Stiles, L. E., Bourne, K., et al. (2019). The face of postural tachycardia syndrome – insights from a large cross‑sectional online community‑based survey. J Intern Med, 286(4), 438–448. https://doi.org/10.1111/joim.12895
Fedorowski, A. (2019). Postural orthostatic tachycardia syndrome: Clinical presentation, aetiology and management. J Intern Med, 285(4), 352–366. https://doi.org/10.1111/joim.12852
Boris, J. R., Shadiack, E. C., 3rd, McCormick, E. M., et al. (2024). Long‑term POTS outcomes survey: Diagnosis, therapy, and clinical outcomes. J Am Heart Assoc, 13(14), e033485. https://doi.org/10.1161/JAHA.123.033485
Safavi‑Naeini, P., & Razavi, M. (2020). Postural orthostatic tachycardia syndrome. Tex Heart Inst J, 47(1), 57–59. https://doi.org/10.14503/THIJ-19-7060
Ormiston, C. K., Świątkiewicz, I., & Taub, P. R. (2022). Postural orthostatic tachycardia syndrome as a sequela of COVID‑19. Heart Rhythm, 19(11), 1880–1889. https://doi.org/10.1016/j.hrthm.2022.07.014
Vernino, S., Bourne, K. M., Stiles, L. E., et al. (2021). Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting – part 1. Auton Neurosci, 235, 102828. https://doi.org/10.1016/j.autneu.2021.102828
Benarroch, E. E. (2012). Postural tachycardia syndrome: A heterogeneous and multifactorial disorder. Mayo Clin Proc, 87(12), 1214–1225. https://doi.org/10.1016/j.mayocp.2012.08.013
Mar, P. L., & Raj, S. R. (2020). Postural orthostatic tachycardia syndrome: Mechanisms and new therapies. Annu Rev Med, 71, 235–248. https://doi.org/10.1146/annurev-med-041818-011630
Raj, S. R., Bourne, K. M., Stiles, L. E., et al. (2021). Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health expert consensus meeting – part 2. Auton Neurosci, 235, 102836. https://doi.org/10.1016/j.autneu.2021.102836
Fedorowski, A., Li, H., Yu, X., et al. (2017). Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace, 19(7), 1211–1219. https://doi.org/10.1093/europace/euw154
Bryarly, M., Phillips, L. T., Fu, Q., Vernino, S., & Levine, B. D. (2019). Postural orthostatic tachycardia syndrome: JACC focus seminar. J Am Coll Cardiol, 73(10), 1207–1228. https://doi.org/10.1016/j.jacc.2018.11.059
Goodman, B. P. (2018). Evaluation of postural tachycardia syndrome (POTS). Auton Neurosci, 215, 12–19. https://doi.org/10.1016/j.autneu.2018.04.004
Vernino, S., & Stiles, L. E. (2018). Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding. Auton Neurosci, 215, 78–82. https://doi.org/10.1016/j.autneu.2018.04.005
Benrud‑Larson, L. M., Dewar, M. S., Sandroni, P., et al. (2002). Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc, 77(6), 531–537. https://doi.org/10.4065/77.6.531
Fu, Q., & Levine, B. D. (2018). Exercise and non‑pharmacological treatment of POTS. Auton Neurosci, 215, 20–27. https://doi.org/10.1016/j.autneu.2018.07.001
Schiweck, N., Langer, K., Maier, A., Vilser, D., & Spiegler, J. (2026). Systematic literature review: Treatment of postural orthostatic tachycardia syndrome (POTS). Clin Auton Res, 36(1), 3–16. https://doi.org/10.1007/s10286-025-01172-2
Wheatley‑Guy, C. M., Shea, M. G., Parks, J. K., et al. (2023). Semi‑supervised exercise training program more effective for individuals with postural orthostatic tachycardia syndrome in randomized controlled trial. Clin Auton Res, 33(6), 659–672. https://doi.org/10.1007/s10286-023-00970-w
Pierson, B. C., Apilado, K., Franzos, M. A., et al. (2025). Oral medications for the treatment of postural orthostatic tachycardia syndrome: A systematic review of studies before and during the COVID‑19 pandemic. Front Neurol, 15, 1515486. https://doi.org/10.3389/fneur.2024.1515486
Wells, R., Elliott, A. D., Mahajan, R., et al. (2018). Efficacy of therapies for postural tachycardia syndrome: A systematic review and meta-analysis. Mayo Clin Proc, 93(8), 1043–1053. https://doi.org/10.1016/j.mayocp.2018.01.025
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Paulina Sumlet, Izabela Małajewicz, Weronika Spychalska, Wiktoria Kurasińska, Martin Kolm, Zuzanna Chmielewska, Kinga Drzewińska , Weronika Suszczyńska, Maria Gofron, Michał Duliński
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
